Affordable Access

Publisher Website

Monitoring of PAEMs and beta-agonists in urine for a small group of experimental subjects and PAEs and beta-agonists in drinking water consumed by the same subjects

Authors
Journal
Journal of Hazardous Materials
0304-3894
Publisher
Elsevier
Publication Date
Volume
277
Identifiers
DOI: 10.1016/j.jhazmat.2014.02.024
Keywords
  • Urine
  • Phthalate Ester Metabolites
  • Beta-Agonists
  • Phthalate Esters
  • Lc–Ms/Ms

Abstract

Abstract This 5-month study contains two parts: (1) to monitor the concentrations of 11 phthalate esters metabolites (PAEMs) and two beta-agonists in human urine samples collected from a small group of consented participants including 16 females and five males; and (2) to analyze the residues of phthalate esters (PAEs) and beta-agonists in various categories of drinking water consumed by the same group of subjects. Each category of human urine and drinking water had 183 samples of its own. The analytical results showed that nine PAEMs were detected in human urine and eight PAEs were detected in drinking water samples. It was found that average concentrations of PAEMs increased as the age increased, but no significant difference between sexes. Further, using the principal component analysis, the loadings of age effect were found to be two times greater than that of gender effect in terms of four DEHP metabolites. Regarding beta-agonists of concern (i.e., ractopamine and salbutamol), they were neither detected in human urine nor drinking water samples in this study.

There are no comments yet on this publication. Be the first to share your thoughts.